PYREXIA is the #10 most commonly reported adverse reaction for OXALIPLATIN, manufactured by Accord Healthcare Inc.. There are 2,773 FDA adverse event reports linking OXALIPLATIN to PYREXIA. This represents approximately 2.2% of all 127,128 adverse event reports for this drug.
OXALIPLATIN has an overall safety score of 92 out of 100. Patients taking OXALIPLATIN who experience pyrexia should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
Reporting Frequency
PYREXIA2,773 of 127,128 reports
PYREXIA is a less commonly reported adverse event for OXALIPLATIN, but still significant enough to appear in the safety profile.
Other Side Effects of OXALIPLATIN
In addition to pyrexia, the following adverse reactions have been reported for OXALIPLATIN:
PYREXIA has been reported as an adverse event in 2,773 FDA reports for OXALIPLATIN. This does not prove causation, but indicates an association observed in post-market surveillance data.
How common is PYREXIA with OXALIPLATIN?
PYREXIA accounts for approximately 2.2% of all adverse event reports for OXALIPLATIN, making it a notable side effect.
What should I do if I experience PYREXIA while taking OXALIPLATIN?
If you experience pyrexia while taking OXALIPLATIN, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.
Disclaimer: This analysis is based on FDA adverse event reports and is for informational purposes only. Reports do not prove causation. Always consult your healthcare provider.